Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1994;23:823-826

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Himeno, H.
Right arrow Articles by Brecher, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Himeno, H.
Right arrow Articles by Brecher, P.

Hypertension, Vol 23, 823-826, Copyright © 1994 by American Heart Association


ARTICLES

Angiotensin II alters aortic fibronectin independently of hypertension

H Himeno, DC Crawford, M Hosoi, AV Chobanian and P Brecher
Boston University School of Medicine, MA 02118.

We performed these studies to assess the potential role of hemodynamic forces in mediating the changes in aortic fibronectin mRNA expression that occur in the rat in response to angiotensin II administration. With the use of an acute hypertensive model involving a 3-day infusion with a pressor dose of angiotensin II given by osmotic minipump, a selective increase in fibronectin mRNA expression but not of several other extracellular matrix genes was documented. This change was inhibited by losartan, indicating the importance of angiotensin receptors in the response. Prazosin, hydralazine, or L-arginine added to the drinking water all lowered the angiotensin II-induced increase in blood pressure but did not attenuate the increase in fibronectin mRNA expression. Angiotensin-converting enzyme inhibition using trandolapril did reduce fibronectin mRNA in the angiotensin II-infusion model, despite an inability to reduce blood pressure, whereas when angiotensin I was infused, quinapril lowered both blood pressure and fibronectin expression even at doses that did not completely normalize blood pressure. These studies suggest that angiotensin II induced an increase in aortic fibronectin mRNA that was not dependent solely on blood pressure.


This article has been cited by other articles:


Home page
HypertensionHome page
H. D. Intengan and E. L. Schiffrin
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Hypertension, September 1, 2001; 38(3): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, J. Blanco, and J. Egido
Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-{{kappa}}B and AP-1 in the Kidney : Role of AT1 and AT2 Receptors
Am. J. Pathol., May 1, 2001; 158(5): 1743 - 1756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al.
Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells
J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. K. Magnusson and D. F. Mosher
Fibronectin : Structure, Assembly, and Cardiovascular Implications
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1363 - 1370.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. G. Birukov, S. Lehoux, A. A. Birukova, R. Merval, V. A. Tkachuk, and A. Tedgui
Increased Pressure Induces Sustained Protein Kinase C–Independent Herbimycin A–Sensitive Activation of Extracellular Signal–Related Kinase 1/2 in the Rabbit Aorta in Organ Culture
Circ. Res., December 19, 1997; 81(6): 895 - 903.
[Abstract] [Full Text]


Home page
StrokeHome page
S. Nag and D. W. Kilty
Cerebrovascular Changes in Chronic Hypertension : Protective Effects of Enalapril in Rats
Stroke, May 1, 1997; 28(5): 1028 - 1034.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
A. V. Chobanian and R. W. Alexander
Exacerbation of Atherosclerosis by Hypertension: Potential Mechanisms and Clinical Implications
Arch Intern Med, September 23, 1996; 156(17): 1952 - 1956.
[Abstract] [PDF]


Home page
HypertensionHome page
H. Kato, J. Hou, A. V. Chobanian, and P. Brecher
Effects of Angiotensin II Infusion and Inhibition of Nitric Oxide Synthase on the Rat Aorta
Hypertension, August 1, 1996; 28(2): 153 - 158.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
N. Bardy, R. Merval, J. Benessiano, J.-L. Samuel, and A. Tedgui
Pressure and Angiotensin II Synergistically Induce Aortic Fibronectin Expression in Organ Culture Model of Rabbit Aorta: Evidence for a Pressure-Induced Tissue Renin-Angiotensin System
Circ. Res., July 1, 1996; 79(1): 70 - 78.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. D. Wang, S. Xu, D. G. Johns, Y. Du, M. T. Quinn, A. J. Cayatte, and R. A. Cohen
Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice
Circ. Res., May 9, 2001; 88(9): 947 - 953.
[Abstract] [Full Text] [PDF]